German Co. Loses 3 Patents As Suit Against J&J Backfires
A Johnson & Johnson unit wasn't infringing three of MorphoSys AG's patents with its multiple myeloma drug Darzalex, and even if it had been, the patent claims aren't enforceable, a Delaware...To view the full article, register now.
Already a subscriber? Click here to view full article